Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-01-18 @ 2:42 AM
Study NCT ID:
NCT02921256
Status:
COMPLETED
Last Update Posted:
2025-12-04
First Post:
2016-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-30
First Submit QC Date:
None
Study First Post Date:
2016-10-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-03-08
Results First Submit QC Date:
None
Results First Post Date:
2023-06-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-19
Last Update Post Date:
2025-12-04
Last Update Post Date Type:
ESTIMATED